Ethanol drug interaction with chlordiazepoxide and pentobarbital

Area of Science:

• Pharmacology
• Toxicology
• Neuroscience

Background:

• Drug interactions involving ethanol are a significant public health concern.
• Understanding the synergistic effects of ethanol with other central nervous system depressants is crucial for clinical safety.

Purpose of the Study:

• To investigate the drug interactions between ethanol and pentobarbital.
• To investigate the drug interactions between ethanol and chlordiazepoxide.
• To quantify the behavioral and lethal effects of these combined drug treatments.

Main Methods:

• Drug interactions were studied in mice using oral ethanol combined with intraperitoneal pentobarbital or chlordiazepoxide.
• Blood concentrations of drugs and metabolites were measured using gas chromatography and high-performance liquid chromatography.
• Lethality and loss-of-righting reflex were used as indicators of behavioral drug interactions.

Main Results:

• Ethanol and pentobarbital, as well as ethanol and chlordiazepoxide, exhibited supra-additive (synergistic) interactions.
• The interaction between ethanol and pentobarbital was stronger than that between ethanol and chlordiazepoxide.
• Ethanol pretreatment more significantly altered dose-response curves for loss-of-righting reflex compared to lethality.
• Pentobarbital biotransformation was decreased, and chlordiazepoxide metabolism was altered, leading to demethylchlordiazepoxide accumulation.

Conclusions:

• Ethanol synergistically enhances the central nervous system depressant effects of both pentobarbital and chlordiazepoxide in mice.
• The observed drug interactions are linked to altered drug metabolism and blood concentrations.
• These findings highlight the complex pharmacodynamic and pharmacokinetic interactions between ethanol and common sedative-hypnotic drugs.